A Columbia-based digital health company focused on cardiometabolic care has issued four new patents, achieving a total of 54 patent grants.

In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

A Review of the Latest Innovations,” published in the February 2025 issue of Journal of Clinical Endocrinology & Metabolism ...